OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Technologies for Direct Detection of Covalent Protein–Drug Adducts
Elma Mons, Robbert Q. Kim, Monique P. C. Mulder
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 547-547
Open Access | Times Cited: 14
Elma Mons, Robbert Q. Kim, Monique P. C. Mulder
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 547-547
Open Access | Times Cited: 14
Showing 14 citing articles:
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo Augusto Massarico Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 37
Laura Hillebrand, Xiaojun Julia Liang, Ricardo Augusto Massarico Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 37
Multi-tiered chemical proteomic maps of tryptoline acrylamide–protein interactions in cancer cells
Evert Njomen, Rachel E. Hayward, Kristen E. DeMeester, et al.
Nature Chemistry (2024) Vol. 16, Iss. 10, pp. 1592-1604
Closed Access | Times Cited: 9
Evert Njomen, Rachel E. Hayward, Kristen E. DeMeester, et al.
Nature Chemistry (2024) Vol. 16, Iss. 10, pp. 1592-1604
Closed Access | Times Cited: 9
N‐Cyanopiperazines as Specific Covalent Inhibitors of the Deubiquitinating Enzyme UCHL1
Mirko Schmidt, Christian Grethe, Sarah Recknagel, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 12
Open Access | Times Cited: 5
Mirko Schmidt, Christian Grethe, Sarah Recknagel, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 12
Open Access | Times Cited: 5
Covalent hits and where to find them
Simon C. C. Lucas, J. Henry Blackwell, Sarah H. Hewitt, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 3, pp. 100142-100142
Open Access | Times Cited: 5
Simon C. C. Lucas, J. Henry Blackwell, Sarah H. Hewitt, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 3, pp. 100142-100142
Open Access | Times Cited: 5
Covalent fragment-based drug discovery for target tractability
William J. McCarthy, Antonie J. van der Zouwen, Jacob T. Bush, et al.
Current Opinion in Structural Biology (2024) Vol. 86, pp. 102809-102809
Open Access | Times Cited: 4
William J. McCarthy, Antonie J. van der Zouwen, Jacob T. Bush, et al.
Current Opinion in Structural Biology (2024) Vol. 86, pp. 102809-102809
Open Access | Times Cited: 4
Systematic Targeting of Protein Complexes with Molecular COUPLrs
Diane Yang, Stefan Harry, Harrison B. Chong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
Diane Yang, Stefan Harry, Harrison B. Chong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
Target Fishing Reveals a Novel Mechanism of N-Acylamino Saccharin Derivatives Targeting Glyceraldehyde-3-Phosphate Dehydrogenase toward Cyanobacterial Blooms Control
Hongxuan Cao, Zeyue Huang, Zheng Liu, et al.
Journal of Agricultural and Food Chemistry (2024)
Closed Access | Times Cited: 1
Hongxuan Cao, Zeyue Huang, Zheng Liu, et al.
Journal of Agricultural and Food Chemistry (2024)
Closed Access | Times Cited: 1
N‐Cyanopiperazines as Specific Covalent Inhibitors of the Deubiquitinating Enzyme UCHL1
Mirko Schmidt, Christian Grethe, Sarah Recknagel, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 12
Open Access
Mirko Schmidt, Christian Grethe, Sarah Recknagel, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 12
Open Access
Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review
Muhammad Salman Hameed, Hongxuan Cao, Guo Li, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access
Muhammad Salman Hameed, Hongxuan Cao, Guo Li, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access
Advancing KRAS drug discovery: A deep dive into biochemical, biophysical, and cellular assays for the identification and optimization of KRAS inhibitors
Anthony N. Milin, John P. Giddens, Abby Marquez
Elsevier eBooks (2024), pp. 61-91
Closed Access
Anthony N. Milin, John P. Giddens, Abby Marquez
Elsevier eBooks (2024), pp. 61-91
Closed Access
Achieving High Affinity for a Bacterial Lectin with Reversible Covalent Ligands
Giulia Antonini, Anna Bernardi, Émilie Gillon, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 19546-19560
Closed Access
Giulia Antonini, Anna Bernardi, Émilie Gillon, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 19546-19560
Closed Access
Covalent Inhibitors of MAP Kinases
Surya K. De
Drug design and discovery (2024), pp. 159-189
Closed Access
Surya K. De
Drug design and discovery (2024), pp. 159-189
Closed Access
Emerging opportunities for intact and native protein analysis using chemical proteomics
Alexis N. Edwards, Ku‐Lung Hsu
Analytica Chimica Acta (2024) Vol. 1338, pp. 343551-343551
Closed Access
Alexis N. Edwards, Ku‐Lung Hsu
Analytica Chimica Acta (2024) Vol. 1338, pp. 343551-343551
Closed Access
Progress and prospect of protein detection methods based on CRISPR-Cas system
Wentao Xu
Highlights in Science Engineering and Technology (2023) Vol. 66, pp. 267-271
Closed Access
Wentao Xu
Highlights in Science Engineering and Technology (2023) Vol. 66, pp. 267-271
Closed Access
